spacer
home > epc > autumn 2008 > powering up for the challenge
PUBLICATIONS
European Pharmaceutical Contractor

Powering Up for the Challenge

The typical consumer never gives a thought to the over-the-counter medication they purchase, nor to the prescription drug they sign their name for at the pharmacy – other than perhaps to give a rhetorical complaint about the price. In contrast, to any individual in the pharmaceutical industry, every bottle of pills, every jar of medicine and every tube of ointment represent a tremendous achievement; a victory for innovation, science, people, technology, investment and time.

That victory has been the result of a long battle. But today, the fight for new, truly differentiated medicines is getting fiercer. Fewer candidate drugs are being successfully developed. Development costs (getting a successful drug to market) have been climbing for years and now hover at around $1 billion – and that’s rising constantly, despite over 80 per cent of compounds not making it to market. In addition, drugs take eight or more years on average to proceed through the various stages of clinical trials.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Janet Edwards is the Director of Global Clinical Outsourcing and Novel Delivery Options at AstraZeneca. She is responsible for setting overall strategy, defining new operating models for outsourcing, and ensuring operational delivery for all outsourced clinical work. Janet joined AstraZeneca in 2001 as Clinical Development Director for emerging oncology clinical project teams, then held a line management position. Prior to this, she served in a variety of project leadership and project and line management roles for several pharmaceutical companies and a CRO. Following her MBA, Janet worked as a management consultant delivering innovative business solutions on numerous projects along the pharmaceutical value chain to multiple clients. In addition to her MBA, she has a BSc degree and is a Chartered Member of CIPD.
spacer
Janet Edwards
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI China opens with analysis pointing to a surge in growth in 2019

Shanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets – forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation.
More info >>

White Papers

PROTEIN:PROTEIN INTERACTION ANALYSIS

IBA GmbH

Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement